Not only isn’t print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it’s thriving in a most unlikely environment: the point of care
Pharma companies, now marketing high-science drugs, rely more on medical affairs
Five years ago, the notion of medical science liaisons as a guiding voice in the marketing mix was borderline preposterous. Now they’re called upon early and often.
